⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPTI News
Karyopharm Therapeutics Inc.
Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
prnewswire.com
KPTI
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
KPTI
Karyopharm to Participate in Baird's Biotech Discovery Series
prnewswire.com
KPTI
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
KPTI
Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference
prnewswire.com
KPTI
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
KPTI
Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
prnewswire.com
KPTI
Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025
prnewswire.com
KPTI
KPTI
Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis
prnewswire.com
KPTI
KPTI
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
KPTI
KPTI